Serum Vitamin D Level in Behcet’s Disease: Single Center Study from Iraq

Nizar A Jassim¹, Noor Hassan A. Alrasool² and Faiq I Gorial^1,

¹Department of Medicine, College of Medicine, University of Baghdad, Baghdad, Iraq

²Baghdad Teaching Hospital, Rheumatology Unit, Baghdad, Iraq

Cite this paper:
Nizar A Jassim, Noor Hassan A. Alrasool and Faiq I Gorial. Serum Vitamin D Level in Behcet’s Disease: Single Center Study from Iraq. American Journal of Medical Sciences and Medicine. 2016; 4(1):8-10. doi: 10.12691/ajmsm-4-1-2

Abstract

Background: Behcet’s disease (BD) is a multisystemic vasculitis. Low serum vitamin D status is closely associated with disease risk of BD. Objective: To evaluate serum vitamin D level in Iraqi patients with BD. Patients and methods: In this case control study, A 43 patients with BD were diagnosed according to International Study Group Criteria and 24 healthy persons recruited as a control group were enrolled in the study. Total serum 25-hydroxyvitamin D (vitamin D) was assessed in both groups and levels ≥22 ng/ml were considered sufficient, while levels of <22 ng/ml were considered low. Results: The mean age for BD patients was 34.2±9.6 years compared to 31.8±6.5 years in control group. Male represented 69% in BD and 70% of healthy controls. Mean disease duration for BD was 5.9±6.7 years. The mean BMI of BD patients was 27.1±4.5 Kg/m² compared to 27.4±3.5 Kg/m² in controls. The demographic and clinical characteristics of study sample showed no significant clinical difference between patients and controls apart from current smoking which was significantly associated with BD (P < 0.05). Serum vitamin D levels were significantly lower in patients with BD than controls (P<0.001). Serum vitamin D levels were significantly inversely correlated with BD duration. Conclusion: serum vitamin D levels were significantly lower in BD patients compared to controls.

Keywords:
Behcet’s disease serum vitamin D vasculitis Vitamin D and Behcet’s disease

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Kirnap M, Calis M, Kaya N, Muhtaroglu S. Is the Behcet's disease a risk factor for osteoporosis and is relation to cytokines?.Bratisl Lek Listy. 2010; 111(6):340-4.
[2]	Idil A, Gurler A, Boyvat A, et al. The prevalence of Behcet’s disease above the age of 10 years. The results of a pilot study conducted at the Park Primary Health Care Center in Ankara, Turkey. Ophthalmic Epidemiology 2002; 9: 325-31.
[3]	Haroon M, Bond U, Quillinan N, et al. The prevalence of vitamin D deficiency in consecutive new patients seen over a 6-month period in general rheumatology clinics. Clin Rheumatol 2011; 30(6):789-94.
[4]	Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84:18-28.
[5]	Cutolo M, Otsa K. Review: vitamin D, immunity and lupus. Lupus 2008; 17:6-10.
[6]	Ben-Zvi I, Aranow C, Mackay M, Stanevsky A, Kamen DL, Marinescu LM, et al. The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One 2010; 5(2):e 9193.
[7]	Shoenfeld N, Amital H, Shoenfeld Y. The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease. Nat Clin Pract Rheumatol 2009; 5:99-105.
[8]	Ganeb S, Sabry H, El-Assal MM, et al. Vitamin D levels in patients with Behcet’s disease: Significance and impact on disease measures The Egyptian Rheumatologist (2013) 35, 151-7.
[9]	Lerner A, Shapira Y, Agmon-Levin N, Pacht A, Ben-Ami Shor D, Lo´ pez HM, et al. The clinical significance of 25OH-vitamin D status in celiac disease. Clin Rev Allergy Immunol 2012; 42: 322-30.
[10]	Peelen E, Knippenberg S, Muris AH, et al. Effects of vitamin D on the peripheral adaptive immune system: a review. Autoimmun Rev 2011; 10(12):733-43.
[11]	International Study Group for Behcet's Disease Criteria for diagnosis of Behcet's disease. Lancet 1990, 335:1078-80.
[12]	Hamzaoui K, Hamzaoui A. Vitamin D level and potential impact on immune cells in Behçet’s disease. OA Inflammation .2013; 1(1): 6.
[13]	Ganeb S, Sabry H, El-Assal MM, et al. Vitamin D levels in patients with Behcet’s disease: Significance and impact on disease measures The Egyptian Rheumatologist (2013) 35, 151-7.
[14]	Karatay S, Yildirim K, Karakuzu A,et al . Vitamin D status in patients with Behcet’s Disease. CLINICS 2011; 66(5):721-3.
[15]	Ibrahim M H, Bakheet MS, Abdel Sater KA and Abdel Shakoor M. Wyno. Relationship between vitamin D and disease activity in some rheumatic disease. Academic Journal of Medical Sciences. 2013; 2 (7): 52-6.
[16]	Alkerwi A, Sauvageot N, Gilson G, Stranges S. Prevalence and Correlates of Vitamin D Deficiency and Insufficiency in Luxembourg Adults: Evidence from the Observation of Cardiovascular Risk Factors (ORISCAV-LUX) Study.. Nutrients. 2015 Aug 13;7(8):6780-96.
[17]	.Cutillas-Marco E1, Fuertes-Prosper A, Grant WB, Morales-Suárez-Varela M.Vitamin D deficiency in South Europe: effect of smoking and aging. Photodermatol Photoimmunol Photomed. 2012 Jun; 28(3):159-61.